chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills; Fever; Tiredness; Muscle pain; This is a spontaneous report from a contactable consumer or other non hcp. A 24-year-old (Non pregnant) female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EW0182) via intramuscular route of administration, administered in left arm, on 08May2021 10:35 (at the age of 24 years), as dose 2, single for COVID-19 immunization. Medical history included fungal infection. Concomitant medications included TERBINAFINE HCL taken for fungal infection from 30Mar2021 and ongoing; desogestrel, ethinylestradiol (ISIBLOOM) taken for contraception from 07Apr2021 and ongoing. The patient had no known allergies. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: ER8731) via intramuscular route of administration, administered in left arm, on 17Apr2021 10:30 (at the age of 24 years), as dose 1, single for COVID-19 immunization, in 1-5 days the patient experienced unspecified events on 17Apr2021 14:00, the outcome of the event reported was recovered on unspecified date in 2021, the patient was not received treatment for the events. Prior vaccination, the patient was not infected from COVID-19. Post vaccination, the patient was not tested for COVID-19. The patient was not received prior vaccination within 4 weeks. Within 24 hours on 08May2021 (onset time reported was 02:00 next day), the patient experienced fever, tiredness, muscle pain, chills. The patient was not received treatment for the events. The outcome of the events was recovered on unspecified date in 2021.   Follow-up attempts are completed. No further information is expected.
Received influenza vaccine 10/10/17 and noted onset of fever, headache, nausea on 10/11/17.
Shortly after the vaccination my left shoulder started to tighten up.  When I woke up the following day I could not lift my arm up at all.  Tried warm shower and OTC Meds but no change.  It was no better Friday, Saturday, or Sunday.  Went to hospital ER on Sunday 3/22 for x-ray etc. and diagnosed with calcification tendinitis.   Received 800mg Ibuprofen script.  Feeling slightly better today with more range of motion but still cannot lift arm much.  Still very painful at the core of the joint.
The patient had a vasovagal episode after administration for Pfizer Dose 1. She had a previous history of vasovagal episodes with flu and possibly HPV shots
Left arm pain; Fever; Chills; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 58-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0169) via an unspecified route of administration in the left arm on 24Apr2021 at 15:45 at the age of 58-year-old as a single dose for COVID-19 immunisation. Medical history included covid-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other concomitant medications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732) via an unspecified route of administration in the left arm on 01Apr2021 at 15:45 at the age of 58-year-old, as a single dose for COVID-19 immunisation. On 25Apr2021 at 06:00, the patient experienced left arm pain, fever, chills, and fatigue. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had been tested for COVID-19. On 20Apr2021, the patient underwent SARS-CoV-2 PCR test and the result was found to be negative. The clinical outcome of the events left arm pain, fever, chills, and fatigue were resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
35 weeks pregnant. Estimated delivery date is 3/27/21. Experienced ?covid arm? or large red painful area around site of injection lasted 4 days.  Experienced fever, chills, severe body aches including Braxton Hicks, and head ache for 24-48hrs. Currently 150 lbs.  first pregnancy with no complications thus far.
One day post vax, pt was seen in ER for injection site reaction characterized by swelling to elbow, redness and itchiness. Pt was treated with Benadryl and Zantac.
Information has been received from a physician concerning a 23 month old female patient who on 06-JUN-2008 was vaccinated orally with the first 0.2 ml dose of ROTATEQ. On 01-AUG-2008 and 13-OCT-2008, the patient was vaccinated with the second and third dose of ROTATEQ respectively. It was reported that the patient developed rotavirus after all three doses of ROTATEQ. At the time of the report the patient had improved. The patient sought unspecified medical attention. Additional information has been requested.
Given in upper right arm, top of muscle. My arm swelled within a few hours, 2xs normal size for 3 days. Ice packs, BENADRYL to counter allergic reaction and aspirin for pain. Nine months later I still have pain in upper right arm, especially when tired. Restricted movement in arm by evening. The pain has never left.
I had almost all of the typical symptoms associated with the Moderna except: I had electrical sensations coming  from my brain the following day for the entire day ( as if I had suddenly stopped taking my sertraline, which was not the case) Shooting pains under my left knee throughout the following day These symptoms have disappeared now.
Then he broke into a rash in the chest.; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Then he broke into a rash in the chest.) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 28-Nov-2022,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced RASH (Then he broke into a rash in the chest.). At the time of the report, RASH (Then he broke into a rash in the chest.) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medicine were reported. No treatment medicine were reported.   Reporter did not allow further contact
Got both shots, have still had breakouts of shingles/Suspected vaccination failure; Have still had breakouts of shingles, very mild; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of herpes zoster (the patient had the first ever shingles vaccine many years ago from reporting and got a mild case of shingles).   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.   Additional Information: GSK Receipt Date: 21-APR-2022 Reporter's Comment: This case was reported by the patient via interactive digital media. The patient got both the shots of Shingrix vaccine. The patient still had breakouts of shingles, but very mild. The patient hated to think that, what it would had been like with no shots. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
After mild and expected side effects (stomach ache, mild diarrhea, headaches, tiredness) woke up at 2 am with dizziness on rolling over in bed. Persisted into the morning on arising.
Patient in lab for immunizations in accordance to transplant team request from hospital. Patient given Flu, Hep B, and PPSV23 at visit.
pt had a positive COVID test on 11/29/21 from clinic; 12/4/21 pt brought to ED in full cardiac arrest after EMS called for increasing SOB; EMS found pt down and started CPR; pt did not survive
nausea and dizziness on 03/12/2021 extreme dizziness 03/13/20-current pressure in ears 03/15/2021-current
Case previously recorded as MA2009-3336. Initial case report received from a physician via MedCom on 26 OCT 2009. A 8-month-old child was vaccinated with 0.5 ml S-OIV FLUVIRIN (batch no 100813-7P) i.m. on 24 OCT 2009. No adverse event was reported. Reference no. NA09-07008.
Headache; Hearing impaired; Dizziness; Vomiting; Brain fog for several days; Vertigo; staggered walk/crawl; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3302) via an unspecified route of administration on the right arm on 07Jan2021 at 15:30 as a single dose for COVID-19 immunisation. Medical history included gynecomastia and testosterone low. The patient did not have any allergies to food, medications and other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 10:00 the patient experienced daily headaches and still ongoing. Intermittent hearing phenomenon - reduced, ringing, garbled, and/or amplification of low frequency sounds. Several instances of dizziness that became severe and resulted in staggered walk/crawl and vomiting, lasting several hours. Brain fog for several days after each vertigo incident. The events resulted in doctor or other healthcare professional office/clinic visit and also in emergency room/department or urgent care.     Therapeutic measures were taken as a result of headache, hearing impaired, dizziness, vomiting, brain freeze and vertigo and included treatment with Meclizine. The patient underwent CT(computerized tomography) scan of sinuses, MRI(Magnetic resonance imaging), and various exams on an unknown date and the result was unknown. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, hearing impaired, dizziness, vomiting, brain freeze and vertigo were not recovered at the time of this report.
This spontaneous report was received from a registered pharmacist refers to a patient of unknown age (gender unspecified). The pharmacist reported that he received a call from long term care facility stating that on an unknown date in November 2012, the patient was vaccinated with a dose of PNEUMOVAX23 (lot number, expiration and route not reported) and another dose this week ((November 2012)). The doses were given approximately one week apart. The name of the long term care facility was unknown. No symptoms were reported. No concomitant medications were reported. It was unspecified if patient sought medical attention. Additional information is not expected.
fever of 99.6; body aches; chills; This is a spontaneous report from a contactable other health professional (patient). A 30-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history included COVID-19 on an unknown date (prior vaccination).  The patient's concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), intramuscular at left arm on 15Dec2020 at 10:00 at single dose for COVID-19 immunization and experienced fever of 99.5, body aches, chills, red face, and feeling flushed and headache. The patient experienced (after second shot) fever of 99.6 and body aches with chills after 12 hours. The patient underwent lab tests and procedures which included nasal swab: negative on 18Dec2020. Therapeutic measures were taken as a result of events and included treatment with ALEVE. The patient outcome of the events was recovered.  The information on the batch number has been requested.
Pneumovax 0.5ml given IM left deltoid 11/17/04 at 14:03. Pt returned to office 11/18/04 15:50 with upper arm swelling, hives, erythema, warmth and soreness. Extended to under arm pit. Dr told pt to take antihistamine and report back tom. any other problems.
This spontaneous report was received from a licensed practical nurse, referring to a 19 year old, female patient. The patient's medical history, concurrent conditions and drug reactions/allergies were not reported. On unknown dates, the patient was vaccinated with the three dose series of GARDASIL (dose, route, lot # and expiration date were not reported). Then, on 11-AUG-2015, the patient was vaccinated with an additional dose of GARDASIL 9 by intramuscular route in the left arm (reported as LD), lot # L004014 (expiration date was not reported), because a company representative mistakenly told that it was the Centers for Disease Control and Prevention (CDC) recommendation. No concomitant medications were reported. No adverse effects were reported. No product quality complaint was involved. This is one of several reports received from the same source. Additional information is not expected as all scheduled follow up information has been received.
12OCT97 grandparent noticed some rolling back of eyeballs, jerking of arms, not legs, was drooling;pt in bed doing fine since then, close observation;
Pt was given KINRIX vaccine instead of PEDIARIX vaccine.  Dr.  contacted parent.  Parent states that pt is a little "fussy" otherwise doing ok.  No known reactions noted
My wife had a history of Stroke in January of 2020. She received an injection treatment for her MS and later in the same day she got the first dose of her vaccine on 03/12/2021. Two days later on 03/14/2021. She was hospitalized for one week. She was then transferred to a larger hospital for Rehabilitation for three weeks.
On night of vaccination 1/22/21, I developed mild Left shoulder joint pain. The next day this progressed to moderate-severe joint pain, with associated weakness and limited range of motion, all just at the Left shoulder joint.  It was most intense on 1/23 and 1/24, back to moderate on 1/25, and just minimal today 1/26/2021.  No erythema, swelling or rash noted.  Tylenol had little effect, so I switched to 600-800 mg ibuprofen q6-8hrs for 3 days.
Patient with blanching erythematous macules about 1 cm in size across face, forehead, occiput, and on one heal. No work of breathing. Monitored for 30 minutes and rash resolved.
from 09/28 till 10/08 tingly swollen left hand , and aching leg shins from 10/01 till current date, i have swollen neck/glands? i sometimes feel like i'm choking in bed shortness of breath, some wheezing loss of weight. from 10/15 till 10/22  i "dry heave/vomit" in the mornings (alot of mucous) on going since 1st round dizzy, heart palpitations, joint pains all over my body, lethargy, migraines (i haven't had i migraine since my hysterotomy in 2011)
Patient administered moderna covid vaccine while temperature excursion was ongoing; Patient administered moderna covid vaccine while temperature excursion was ongoing; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patient administered moderna covid vaccine while temperature excursion was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (Patient administered moderna covid vaccine while temperature excursion was ongoing) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient administered moderna covid vaccine while temperature excursion was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (Patient administered moderna covid vaccine while temperature excursion was ongoing). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patient administered moderna covid vaccine while temperature excursion was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (Patient administered moderna covid vaccine while temperature excursion was ongoing) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.  No treatment medication were reported.
TDAP given 10-16-12 redness 21cm x 9cm started 10-21-12 & tenderness with itching.
technician administer their flu vaccine into their upper buttocks, lower back region while the patient was sitting down with no reported adverse event; Initial information was received on 26-Sep-2023 regarding an unsolicited valid  non-serious case received from a pharmacist.  This case involves an unknown age and gender patient to whom technician administer their influenza quadrival A-B high dose HV vaccine [Fluzone high-dose quadrivalent] into their upper buttocks, lower back region while the patient was sitting down with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect influenza quadrival A-B high dose HV vaccine (unknown formulation) (lot number, expiry date, strength, was unknown) via intramuscular route in unknown administration site for Influenza (Influenza immunisation) and technician administer their flu vaccine into their upper buttocks, lower back region while the patient was sitting down with no reported adverse event (product administered at inappropriate site) (Latency: same day). The information on the batch number was requested.  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Pain at injection (2-3 days); vomiting; Low grade fever; Flu-like symptoms, dry cough, runny nose.
Patient vaccinated x3 (Pfizer: 3/31/21, 4/29/21, 2/24/22) Patient tested positive and admitted to hospital on 9/1/22
NO ADVERSE EVENTS NOTICED AT THIS TIME. CALLED CDC AND WAS TOLD THAT INFANT SHOULD BE CALLED IN AND VACCINATED WITH THE CORRECT VACCINE AS SOON AS POSSIBLE. CALLED MOTHER AND SHE STATES SHE WILL BRING CHILD IN FOR THE CORRECT SHOT.
Additional information has been received from the physician on 08/20/02 provided recovery status, A healthcare professional reported that an 18 month old female inadvertently received a fifth dose of Prevnar on 07/20/02. That day, she developed hives over her body. She was treated with Zyrtec (certirizine) and Benadryl (diphenhydramine), She recovered.
This case was reported by a pharmacist via call center representative and described the occurrence of fatigue in a adult patient who received SHINGRIX. In May 2018, the patient received SHINGRIX. In May 2018, less than a week after receiving SHINGRIX, the patient experienced fatigue and appetite lost. On an unknown date, the outcome of the fatigue and appetite lost were unknown. It was unknown if the reporter considered the fatigue and appetite lost to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The healthcare professional reported that SHINGRIX was given to a patient 5 days ago time of reporting. The patient was experiencing extreme fatigue and loss of appetite. The healthcare professional could not access any patient or vaccine information at time of chat.
Fever 101 for 2 days Body aches, chills,headache Severe site reaction- pain,swollen and red entire upper arm - still 5 days after shot
Typical advertised reactions with one exception - Slight numbness/tingling radiating from the inject site - left shoulder. This started about 90 minutes after vaccination. It originated at the injection site and moved down the arm into the left hand. At 120 minutes after injection it moved into the neck, face, ear and scalp - again only on the left side. The following day numbness and tingling sensation is about half as strong. At times it fades and but comes back. Muscle movements were not impacted and sense of touch remained. As of 30 hours after the injection I have not sought out treatment.
We were not able to reach mother to get specific details but sketchy info was given to our interpreter when he returned to our clinic on 5/8/03. The mother said she gave 1 dose of Tylenol because pt hadn't had problems with previous immunizations. His temperature was elevated by evening and the baby had a seizure. He was taken to a hospital ER and was discharged around midnight after the baby's temp was WNL. Only Tylenol was given at ER.
pt recv vax 21JUN95 & on 23FEB97 pt devel chickenpox;It was also reported that another pt (WAES # 97030704) devel chickenpox p/receiving varicella vax SC on 21JUN95;
This is a spontaneous report received from contactable other HCP (patient). A 28-year-old female patient (not pregnant) received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), at the age of 28, in right arm, on Aug 31, 2021, at 20:30, single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. The patient had tremor (shaking hands, appearing randomly through the day for several days), onset Sep 2, 2021, with outcome of not recovered. No therapeutic measures taken as a result of tremor. Additional information: The patient did not receive any other vaccines within 4 weeks prior to COVID-19 vaccine. Prior to vaccination, patient not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. Facility where the most recent COVID-19 vaccine was administered: Hospital. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
headache, low grade fever; 12 hr duration, treated with Tylenol 650 mg BID